314 related articles for article (PubMed ID: 15494606)
21. Emergency treatment of life-threatening intrathecal methotrexate overdose.
Finkelstein Y; Zevin S; Heyd J; Bentur Y; Zigelman Y; Hersch M
Neurotoxicology; 2004 Mar; 25(3):407-10. PubMed ID: 15019303
[TBL] [Abstract][Full Text] [Related]
22. Intracerebral hematoma as a complication of intrathecal methotrexate administration.
Boran P; Tokuc G; Boran BO; Oktem S
Pediatr Blood Cancer; 2008 Jan; 50(1):152-4. PubMed ID: 16615061
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid exchange after intrathecal methotrexate overdose. A report of two cases.
Jakobson AM; Kreuger A; Mortimer O; Henningsson S; Seidel H; Moe PJ
Acta Paediatr; 1992 Apr; 81(4):359-61. PubMed ID: 1606401
[TBL] [Abstract][Full Text] [Related]
24. [Carboxypeptidase-G2-rescue in a woman with methotrexate-induced renal failure].
von Poblozki A; Dempke W; Schmoll HJ
Med Klin (Munich); 2000 Aug; 95(8):457-60. PubMed ID: 10985069
[TBL] [Abstract][Full Text] [Related]
25. Accidental overdose of intrathecal cytarabine in children.
Thienprayoon R; Heym KM; Pelfrey L; Bowers DC
Ann Pharmacother; 2013 May; 47(5):e24. PubMed ID: 23606548
[TBL] [Abstract][Full Text] [Related]
26. Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene.
Zobeck MC; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
Pediatr Blood Cancer; 2021 Aug; 68(8):e29036. PubMed ID: 33788417
[TBL] [Abstract][Full Text] [Related]
27. Intrathecal leucovorin after intrathecal methotrexate overdose.
Jardine LF; Ingram LC; Bleyer WA
J Pediatr Hematol Oncol; 1996 Aug; 18(3):302-4. PubMed ID: 8689347
[TBL] [Abstract][Full Text] [Related]
28. Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.
Rolf N; Boehm H; Kaindl AM; Lauterbach I; Suttorp M
Klin Padiatr; 2006; 218(6):350-4. PubMed ID: 17080338
[TBL] [Abstract][Full Text] [Related]
29. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
Strunk T; Gottschalk S; Goepel W; Bucsky P; Schultz C
Med Pediatr Oncol; 2003 Jan; 40(1):48-50. PubMed ID: 12426687
[No Abstract] [Full Text] [Related]
30. Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy.
Krause AS; Weihrauch MR; Bode U; Fleischhack G; Elter T; Heuer T; Engert A; Diehl V; Josting A
Leuk Lymphoma; 2002 Nov; 43(11):2139-43. PubMed ID: 12533039
[TBL] [Abstract][Full Text] [Related]
31. Effective removal of methotrexate by high-flux hemodialysis.
Saland JM; Leavey PJ; Bash RO; Hansch E; Arbus GS; Quigley R
Pediatr Nephrol; 2002 Oct; 17(10):825-9. PubMed ID: 12376811
[TBL] [Abstract][Full Text] [Related]
32. [Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration].
Le Guillou F; Dominique S; Dubruille V; Contentin N; Tilly H; Nouvet G
Rev Mal Respir; 2003 Apr; 20(2 Pt 1):273-7. PubMed ID: 12844025
[TBL] [Abstract][Full Text] [Related]
33. Reduced-dose carboxypeptidase-G2 successfully lowers elevated methotrexate levels in an adult with acute methotrexate-induced renal failure.
Trifilio S; Ma S; Petrich A
Clin Adv Hematol Oncol; 2013 May; 11(5):322-3. PubMed ID: 23880719
[No Abstract] [Full Text] [Related]
34. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
35. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
Turello R; Rentsch K; Di Paolo E; Popovic MB
Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
[TBL] [Abstract][Full Text] [Related]
36. [Unintentional intrathecal administration of a tenfold dose of methotrexate].
Kaczmarek M; Radwańska U
Acta Haematol Pol; 1990; 21(2):228-30. PubMed ID: 2131723
[TBL] [Abstract][Full Text] [Related]
37. Glucarpidase following high-dose methotrexate: update on development.
Patterson DM; Lee SM
Expert Opin Biol Ther; 2010 Jan; 10(1):105-11. PubMed ID: 19925307
[TBL] [Abstract][Full Text] [Related]
38. Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity.
Tuffaha HW; Al Omar S
J Oncol Pharm Pract; 2011 Jun; 17(2):136-40. PubMed ID: 19833686
[TBL] [Abstract][Full Text] [Related]
39. Methotrexate nephrotoxicity: Novel treatment, new approach.
Iqbal S; Armaghani A; Aiyer R; Kazory A
J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
